Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Surgical Pathology Clinics|November 28, 2015
Active Surveillance: Pathologic and Clinical Variables Associated with OutcomeMark Pomerantz
Annual Review of Medicine|September 22, 2006
Advances in the treatment of prostate cancerMark Pomerantz, Philip Kantoff
The Urologic Clinics of North America|October 23, 2012
Moving toward personalized medicine in castration-resistant prostate cancerEliezer M Van Allen, Mark Pomerantz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2023
Early Treatment Intensification in Metastatic Hormone-Sensitive Prostate CancerJeremiah Wala, Paul Nguyen, Mark Pomerantz
Prostate Cancer and Prostatic Diseases|January 25, 2022
Metabolic syndrome and its pharmacologic treatment are associated with the time to castration-resistant prostate cancerJiun-Hung Geng, Anna Plym, Kathryn L Penney, et al.
The Oncologist|July 18, 2023
TERT Promoter Mutations Frequency Across Race, Sex, and Cancer TypeTalal El Zarif, Marc Machaalani, Rashad Nawfal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 10, 2010
Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapyTong Sun, Gwo-Shu Mary Lee, Lillian Werner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2010
Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohortTong Sun, Lee Gwo-Shu Mary, William K Oh, et al.
Pageof 7